Results 201 to 210 of about 233,946 (332)

Detection of Diagnostic Antibodies in Immune‐Mediated Diseases: A Focus on Antigens and Technologies

ChemBioChem, Volume 27, Issue 9, 14 May 2026.
This review explores autoantibody detection in immune‐mediated diseases, highlighting autoantigens including post‐translational modifications. We compared enzyme‐linked immunosorbent assay and indirect immunofluorescence with automated chemiluminescence platforms.
Silvia Bracci, Feliciana Real‐Fernandez, Federico Pratesi, Francesca Nuti, Paolo Rovero, Anna Maria Papini   +5 more
wiley   +1 more source

A systematic review and meta-analysis of risk prediction models for post-thrombotic syndrome in patients with deep vein thrombosis. [PDF]

Heliyon, 2023
Guo X, Xu H, Zhang J, Hao B, Yang T.
europepmc   +1 more source

Activated Platelet–Released Heat Shock Protein 90α Triggers Autophagy‐Dependent Neutrophil Extracellular Trap Formation and Amplifies Sepsis

Advanced Science, Volume 13, Issue 25, 4 May 2026.
HSP90α is significantly upregulated in platelets from sepsis patients, with its origin from megakaryocyte‐derived trafficking. Furthermore, activated platelets secrete HSP90α into the extracellular space in both free and exosome‐associated forms. Finally, extracellular HSP90α directly engages TLR4 on neutrophils to induce autophagy, leading to NET ...
Chengbo Wang, Maodong Leng, Chenchen Sun, Jingyu Cao, Linfei Li, Yangyang Jia, Yongshuai Han, Yuchun Liu, Yaodong Zhang, Chenglong Zhang, Yingli Men, Ningyuan Liu, Yibing Cheng, Yixia Zhang, Ya Li, Zhenlong Li, Lidan Cui, Xiangzhan Zhu   +17 more
wiley   +1 more source

Hyperuricemia-Informed Survival Machine-Learning Prediction of Post-Thrombotic Syndrome After Unprovoked DVT: A Dual-Center Prospective Study. [PDF]

Diagnostics (Basel)
Li Y, Deng H, Gu Y.
europepmc   +1 more source

French Canadian cross-cultural adaptation of CAPTSure©, an index for the Clinical Assessment of Post-Thrombotic Syndrome in children. [PDF]

J Patient Rep Outcomes, 2023
Pelland-Marcotte MC, Stavrakoukas A, Wong G, Santiago R, Avila L.   +4 more
europepmc   +1 more source

Clinical Study on the Association Between Lipoprotein(a) Levels and Prognosis in Patients With Acute Ischemic Stroke

Brain and Behavior, Volume 16, Issue 5, May 2026.
Elevated lipoprotein(a) is independently associated with poor 3‐month outcomes in acute ischemic stroke. Combining Lp(a) with NIHSS improves prognostic accuracy. ABSTRACT Background Lipoprotein(a) (Lp(a)) is a known cardiovascular risk factor, but its role in acute ischemic stroke (AIS) prognosis remains unclear. This study investigated the association
Xinyi Chen, Yueyu Zhang, Yi Tang, Jie Hu, Xun He, Juncang Wu   +5 more
wiley   +1 more source

Impact of hemodynamic doppler ultrasound parameters on patency and post-thrombotic syndrome in patients with iliofemoral venous stents. [PDF]

Sci Rep
Skaff Y, Douane F, Chastaingt L, Morard M, Maurel B, Kallassy C, Espinasse B, Dari L, Espitia O.   +8 more
europepmc   +1 more source

Fruquintinib Plus TAS‐102 With or Without SBRT as Third‐ Or Later‐Line Therapy for Metastatic Colorectal Cancer: Preliminary Results From a Prospective Phase II Trial

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Both fruquintinib and TAS‐102 monotherapies are guideline‐recommended for third‐line treatment of metastatic colorectal cancer (mCRC). This study aimed to analyze the preliminary outcomes of fruquintinib combined with TAS‐102, with or without stereotactic body radiation therapy (SBRT), as a third‐ or later‐line therapy for mCRC.
Yi Wang, Jianfen Xu, Linchun Liang, Yunjie Chen, Leizheng Fei, Jing Hu, Jianjiong Li, Yi Lu, Feng Ren, Ke Chen, Yanping Shen, Qingsong Tao, Zhi Fang, Kaitai Liu, Hua Ye, Jing Zhang, Yunbao Xu, Haoxun Mao, Chen Zhang, Chuangzhou Rao   +19 more
wiley   +1 more source

Impact of Endovascular Treatment on the Development of Post-Thrombotic Syndrome in Iliac and Iliofemoral Deep Vein Thrombosis. [PDF]

J Clin Med
Puche Palao G, Trujillo-Santos J, Otálora S, Guirado-Torrecillas L, Pagán-Escribano J, Demelo-Rodríguez P.   +5 more
europepmc   +1 more source

Current Knowledge of Immune Checkpoint Inhibitor‐Induced Thrombocytopenia: Epidemiology, Mechanisms, and Management

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Immune checkpoint inhibitors (ICIs) have been widely adopted in the treatment of malignant tumors, and their durable antitumor effects have revolutionized cancer therapy. Immune checkpoint inhibitor‐induced thrombocytopenia (ICIIT) represents a rare but potentially severe or even fatal hematologic toxicity associated with immunotherapy ...
Youran Dai, Wenhui Yang, Zexing Sun, Linfeng Wu, Keding Shao, Dijiong Wu   +5 more
wiley   +1 more source